Welcome guest, Login | Register


Veronica Rodriguez-Bravo


Ph.D. in Pathology & Cell Biology, School of Medicine, University of Barcelona, Barcelona, Spain, 2007

Current position

Assistant Professor, Pathology and Oncological Sciences, Mount Sinai School of Medicine, present


  1. Carceles-Cordon, M., Rodriguez-Fernandez, I., Rodriguez-Bravo, V., Cordon-Cardo, C. and Domingo-Domenech, J. (2016). In vivo bioluminescence imaging of luciferase-labeled cancer cells. Bio-protocol 6(6): e1762. 
  2. Williams, E. S., Rodriquez-Bravo, V., Chippada-Venkata, U., De Ia Iglesia-Vicente, J., Gong, Y., Galsky, M., Oh, W., Cordon-Cardo, C. and Domingo-Domenech, J. (2015). Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells. J Vis Exp(105): 53182.
  3. Vidal, S. J., Rodriguez-Bravo, V., Quinn, S. A., Rodriguez-Barrueco, R., Lujambio, A., Williams, E., Sun, X., de la Iglesia-Vicente, J., Lee, A., Readhead, B., Chen, X., Galsky, M., Esteve, B., Petrylak, D. P., Dudley, J. T., Rabadan, R., Silva, J. M., Hoshida, Y., Lowe, S. W., Cordon-Cardo, C. and Domingo-Domenech, J. (2015). A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer. Cancer Cell 27(2): 223-239. Cover and Preview.
  4. Rodriguez-Bravo, V., Maciejowski, J., Corona, J., Buch, H. K., Collin, P., Kanemaki, M. T., Shah, J. V. and Jallepalli, P. V. (2014). Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor. Cell 156(5): 1017-1031. *Comment in: Mitosis: a safety net for successful mitosis. [Nat Rev Mol Cell Biol. 2014] Nuclear pores set the speed limit for mitosis. [Cell. 2014]
  5. Vidal, S. J., Rodriguez-Bravo, V., Galsky, M., Cordon-Cardo, C. and Domingo-Domenech, J. (2014). Targeting cancer stem cells to suppress acquired chemotherapy resistance. Oncogene 33(36): 4451-4463.
  6. Vidal, S. J., Quinn, S. A., de la Iglesia-Vicente, J., Bonal, D. M., Rodriguez-Bravo, V., Firpo-Betancourt, A., Cordon-Cardo, C. and Domingo-Domenech, J. (2014). Isolation of cancer stem cells from human prostate cancer samples. J Vis Exp(85).
  7. Domingo-Domenech, J., Vidal, S. J., Rodriguez-Bravo, V., Castillo-Martin, M., Quinn, S. A., Rodriguez-Barrueco, R., Bonal, D. M., Charytonowicz, E., Gladoun, N., de la Iglesia-Vicente, J., Petrylak, D. P., Benson, M. C., Silva, J. M. and Cordon-Cardo, C. (2012). Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell 22(3): 373-388.
  8. Burkard, M. E., Maciejowski, J., Rodriguez-Bravo, V., Repka, M., Lowery, D. M., Clauser, K. R., Zhang, C., Shokat, K. M., Carr, S. A., Yaffe, M. B. and Jallepalli, P. V. (2009). Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells. PLoS Biol 7(5): e1000111.
  9. Lindqvist, A., Rodriguez-Bravo, V. and Medema, R. H. (2009). The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 185(2): 193-202.
  10. Rodriguez-Bravo, V., Guaita-Esteruelas, S., Salvador, N., Bachs, O. and Agell, N. (2007). Different S/M checkpoint responses of tumor and non tumor cell lines to DNA replication inhibition. Cancer Res 67(24): 11648-11656.
  11. Rodriguez-Bravo, V., Guaita-Esteruelas, S., Florensa, R., Bachs, O. and Agell, N. (2006). Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells. Cancer Res 66(17): 8672-8679.
Protocols by Veronica Rodriguez-Bravo
  1. In vivo Bioluminescence Imaging of Luciferase-labeled Cancer Cells